Amylin seeks FDA OK on once-weekly diabetes drug (AP)

AP - Biotechnology company Amylin Pharmaceuticals Inc. said Tuesday it asked the Food and Drug Administration to approve its highly anticipated once-weekly injectable diabetes treatment exenatide LAR.